Combined with our study, CELSR2 is a novel potential therapeutic target for gliomas, and CELSR2 silencing disrupts the Wnt/β-catenin pathway and induces cell cycle arrest and tumor proliferation inhibition, which is considered as one of the therapeutic strategies in cancer treatment [33]. The gene discussed is CELSR2; the disease is neoplasm.